Zovirax Intravenous injection

Active ingredients: Aciclovir

Product name and form

Zovirax I.V. 250 mg.

Zovirax I.V. 500 mg.

Pharmaceutical Form

Intravenous injection.

Qualitative and quantitative composition

250 mg aciclovir or 500 mg aciclovir in each vial.

Excipients with known effect: Sodium hydroxide

For the full list of excipients, see section 6.1.

Active Ingredient

Acyclovir is an antiviral agent with activity against herpes simplex virus and varicella-zoster virus. Acyclovir inhibits the DNA polymerase of the virus, preventing further proliferation.

List of Excipients

Sodium hydroxide (used to adjust pH)

Pack sizes and marketing

Type I glass vials closed with butyl or bromobutyl rubber stoppers secured by aluminium collars.

17 ml-nominal capacity of vial containing 250 mg aciclovir.

25 ml-nominal capacity of vial containing 500 mg aciclovir.

Marketing authorization holder

The Wellcome Foundation Ltd., 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

Trading as: GlaxoSmithKline UK, Stockley Park West, Uxbridge, Middlesex, UB11 1BT

Marketing authorization dates and numbers

PL 00003/0159

Date of first authorisation: 6 April 1982

Date of last renewal: 9 June 1997


Austria, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, France, Hong Kong, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Singapore, Tunisia, United Kingdom, United States, South Africa